By Daniels Porco & Lusardi, LLP | Published May 18, 2017 | Posted in Health Care Law | Tagged Tags: Health Care Law | Comments Off on Scrutiny On FDA Following New Study On Drug Warnings
As we have duly noted in prior select posts, many individuals and enterprises operating within the health care realm in New York and nationally are routinely under intense public and regulatory scrutiny. And among all those industry participants, there is perhaps no other entity so closely perused as the U.S. Food and Drug Administration, especially Read More
Read MoreDoctor-owned medical facilities — chiefly hospitals — are bad for consumers and the public health. No, wait a minute, they’re a positive development that materially promotes a salutary bottom line in a truly broad-based way. Those polar-opposite views are the core bullet points in any debate focusing upon close physician involvement in an ownership capacity Read More
Read More